Allergan will hold special shareholders meeting, as Pershing Square and its partner, Valeant Pharmaceuticals, continue their push for control of the drugmaker. At a meeting on Dec. 18, shareholders of Allergan Inc. will be given the opportunity to vote out most of the company's directors, which could give Bill Ackman's Pershing Square Capital Management LP and Valeant Pharmaceuticals International Inc.